BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 3:33:08 AM | Browse: 102 | Download: 161
 |
Received |
|
2025-06-17 10:17 |
|
Peer-Review Started |
|
2025-06-17 10:19 |
|
First Decision by Editorial Office Director |
|
2025-07-24 08:36 |
|
Return for Revision |
|
2025-07-24 08:36 |
|
Revised |
|
2025-08-01 03:47 |
|
Publication Fee Transferred |
|
2025-08-03 07:24 |
|
Second Decision by Editor |
|
2025-08-28 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-28 06:47 |
|
Articles in Press |
|
2025-08-28 06:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-08 07:59 |
|
Publish the Manuscript Online |
|
2025-09-25 03:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Supatsri Sethasine, Padoemwut Teerawongsakul, Witchakorn Ruamtawee, Nutachat Treerasoradaj and Huttakan Navadurong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Huttakan Navadurong, Lecturer, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Bangkok 10300, Thailand. huttakan.nav@nmu.ac.th |
| Key Words |
Albumin-bilirubin; Metabolic-associated steatotic liver disease; Survival; Hepatic outcomes; Risk prediction |
| Core Tip |
The albumin-bilirubin (ALBI) score, which was developed for hepatocellular carcinoma, showed a strong predictive value for long-term liver-related complications and all-cause mortality in patients with metabolic-associated steatotic liver disease (MASLD). In a cohort of 1163 patients with MASLD, ALBI outperformed fibrosis-4 and the existing prognostic models. Incorporating ALBI significantly improved the predictive accuracy for long-term complications and mortality, suggesting its potential role as a valuable and noninvasive tool for long-term risk stratification in MASLD. |
| Publish Date |
2025-09-25 03:33 |
| Citation |
Sethasine S, Teerawongsakul P, Ruamtawee W, Treerasoradaj N, Navadurong H. Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease. World J Gastroenterol 2025; 31(37): 110829 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i37/110829.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i37.110829 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
